Study Evaluating Two Dose Levels of Targretin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL)

Sponsor and Collaborators     
Eisai Inc.

Contact
Gail Howard     
201-746-2702     
[email protected]


Continue Reading

Investigator
Gary Palmer, MD     
Eisai Inc.

ClinicalTrials.gov Identifier
NCT01007448